BioCatalystWatch
PRMEWorkspace / PRME / OverviewCompany library
Prime Medicine, Inc. logo

Prime Medicine, Inc.

Prime Medicine, Inc. (PRME)

Website

Price
Market cap
Next catalystPhase 1/2 initiation planned; prior 2026 guidance not withdrawnPM647 — planned global Phase 1/2 AATD trial · Trial initiationSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

PM577a

ATP7B H1069Q

PreINDP1P2P3FilingApproved
Upcoming / outlook

PM577

ATP7B H1069Q

PreINDP1P2P3FilingApproved
Upcoming / outlook

PM647

SERPINA1 E342K (Pi*Z)

PreINDP1P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

PM359

NCF1 (p47phox)

PreINDP1P2P3FilingApproved
Upcoming / outlook

Cystic Fibrosis program

CFTR

PreINDP1P2P3FilingApproved

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

PM647

SERPINA1 E342K (Pi*Z)

PreINDP1P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

PM577

ATP7B H1069Q

PreINDP1P2P3FilingApproved
Upcoming / outlook

PM359

NCF1 (p47phox)

PreINDP1P2P3FilingApproved
Upcoming / outlook

PM577a

ATP7B H1069Q

PreINDP1P2P3FilingApproved
Upcoming / outlook

Cystic Fibrosis program

CFTR

PreINDP1P2P3FilingApproved

Other pipelines

PM577b

ATP7B R778L

Partner / License out

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

PRME PR & News

PR & News

PRME SEC archive